Enhanced legumain activity links progranulin deficiency to TDP-43 pathology in frontotemporal lobar degeneration
Sophie Robinson(Institut für Schlaganfall- und Demenzforschung), Anja Capell(German Center for Neurodegenerative Diseases), Dieter Edbauer(German Center for Neurodegenerative Diseases), Marvin Reich(German Center for Neurodegenerative Diseases), Christine Van Broeckhoven(VIB-UAntwerp Center for Molecular Neurology), Georg Werner(Ludwig-Maximilians-Universität München), Matthew Simon(Denali Therapeutics (United States)), Katrin Buschmann(Ludwig-Maximilians-Universität München), Andrea Ahles(Inserm), Todd Logan(BioMarin (United States)), Thomas Reinheckel(University of Freiburg), Christian Haass(German Center for Neurodegenerative Diseases), Björn Bartels(Roche (Switzerland)), Anika Reifschneider(Ludwig-Maximilians-Universität München), Stefan Engelhardt(Heidelberg University), Gilbert Di Paolo(Denali Therapeutics (United States)), Simon Gutbier(Roche (Switzerland)), Markus Daμμe(Christian-Albrechts-Universität zu Kiel), Eline Wauters(University of Antwerp), Claudia Krenner(Ludwig-Maximilians-Universität München), Maria-Teresa Mühlhofer(German Center for Neurodegenerative Diseases), Quirin Mühlhofer(Ludwig-Maximilians-Universität München), Mihalis S. Kariolis(Denali Therapeutics (United States)), Henrick Riemenschneider(German Center for Neurodegenerative Diseases), Dominik Paquet(LMU Klinikum)
Cited by 5
Related Papers
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
|Immunity|2017|3k
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
|Nature|2008|2.4k
Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production
|Nature|1992|1.8k
Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology
|EMBO Reports|2006|1k
Cardiac fibroblast–derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy
|Journal of Clinical Investigation|2014|993